VYNE Therapeutics Inc. (VYNE) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 24, 2026 filed July 23, 2026 | Stuart Iain CHIEF SCIENTIFIC OFFICER | $13,828 | 15,405 | −14% | No | |
|
|
||||||
| July 24, 2026 filed July 23, 2026 | Domzalski David PRESIDENT AND CEO | $71,261 | 79,391 | −19% | No | |
|
|
||||||
| July 24, 2026 filed July 23, 2026 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | $20,210 | 22,516 | −19% | No | |
|
|
||||||
| July 24, 2026 filed July 23, 2026 | Zeronda Tyler CHIEF FINANCIAL OFFICER | $20,210 | 22,516 | −23% | No | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Stuart Iain CHIEF SCIENTIFIC OFFICER | $1,542 | 2,370 | −2% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free